Skip to main content

Table 2 Characteristics of MSM undergoing HIV testing at MSHC in each study year (2014–2017)

From: Incident HIV infection has fallen rapidly in men who have sex with men in Melbourne, Australia (2013–2017) but not in the newly-arrived Asian-born

 

July 2013 to June 2014

July 2014 to June 2015

July 2015 to June 2016

July 2016 to June 2017

Ptrend 2014–2017

Newly-arrived Asian-born MSMa

Other MSM

p

Newly arrived Asian born MSMa

Other MSM

p

Newly arrived Asian born MSMa

Other MSM

p

Newly arrived Asian born MSMa

Other MSM

p

Newly arrived Asian born MSMa

Other MSM

Individuals tested, n

255b

3,988c

 

291b

4422c

 

402b

5185c

 

581b

5608c

   

HIV testsd, n

409

6365

 

489

7212

 

745

8923

 

1138

10,462

   

Age in yrs., median (IQR)e

26.3 (23.5–30.0)

30.1 (25.3–37.8)

<.0001m

26.7 (23.4–30.7)

30.4 (25.6–38.0)

<.0001m

26.6 (23.5–29.8)

30.4 (25.7–38.2)

<.0001m

26.7 (24.0–30.0)

30.3 (25.6–37.5)

<.0001m

.79n

.07n

Days since previous HIV test, median (IQR)

133 (75–292)

154 (86–316)

.017m

116 (72–234)

144 (83–296)

<.0001m

106 (57–21)

131 (78–270)

<.0001m

114 (73–238)

101 (61–189)

<.0001m

<.001n

<.001n

PrEP use tests nf,g (%)

7 (3.4%)

79 (2.7%)

.55l

39 (5.9%)

721 (10.7%)

<.001l

.22n

<.001n

PrEP n personsf,h (%)

7 (3.5%)

72 (2.7%)

.50l

33 (6.8%)

542 (11.1%)

<.001l

.19n

<.001n

Tests with:

              

Symptoms ng (%)

71 (17.4%)

1549 (24.3%)

.001l

81 (16.6%)

1676(23.2%)

.001l

119 (16.0%)

1976(22.2%)

<.001l

195(17.1%)

2059(19.7%)

.039l

.98n

<.001n

Syphilisg n (%)

3 (0.73%)

78 (1.23%)

.38l

6(1.23%)

117 (1.62%)

.50l

16 (2.15%)

159 (1.78%)

.47l

19 (1.67%)

161 (1.54%)

.73l

.19n

.16n

Pharyngeal gonorrhoeagn (%)

6 (1.47%)

106 (1.67%)

.76l

7(1.43%)

176 (2.44%)

.16l

6 (0.81%)

118 (1.32%)

.23l

4 (0.35%)

68 (0.65%)

.23l

.012n

<.001n

Urethral gonorrhoeagn (%)

8 (1.96%)

145 (2.28%)

.67l

4(0.82%)

192 (2.66%)

.012l

19 (2.55%)

198 (2.22%)

.56l

12 (1.05%)

239 (2.28%)

.007l

.46n

.55n

Urethral chlamydiagn (%)

8 (1.96%)

159 (2.50%)

.49l

6 (1.23%)

194 (2.69%)

.049l

20 (2.75%)

246 (2.75%)

.91l

28 (2.46%)

298 (2.85%)

.45l

.27n

.19n

Anal gonorrhoeag n (%)

11 (2.69%)

180 (2.83%)

.97l

17 (3.48%)

283 (3.92%)

.62l

41 (5.50%)

510 (5.72%)

.81l

61 (5.36%)

535 (5.11%)

.72l

.017n

<.001n

Anal chlamydiag n (%)

31 (7.58%)

308 (4.84%)

.014l

37 (7.57%)

315 (4.37%)

.001l

67 (8.99%)

628 (7.04%)

.047l

89 (7.82%)

740 (7.07%)

.35l

.83n

<.001n

100% condom useg,in (%)

226 (57.4%)

3229 (53.4%)

.12l

255 (56.3%)

3405 (50.5%)

.016l

354 (53.3%)

3804 (47.0%)

.002l

522 (51.9%)

3537 (38.2%)

<.001l

.044n

<.001n

10 or more partnersg,in (%)

39 (9.54%)

852 (13.4%)

.026l

36 (7.36%)

983 (13.6%)

<.001l

48 (6.44%)

1216 (13.6%)

<.001l

110 (9.67%)

1450 (13.9%)

<.001l

.54n

.43n

Positive HIV testsj, n

4

48

 

7

48

 

11

41

 

14

38

   

% testsg

0.98%

0.75%

.62l

1.43%

0.67%

.052l

1.48%

0.46%

<.001l

1.23%

0.36%

<.001l

0.86n

<.001n

% people testedh

1.57%

1.20%

.61l

2.41%

1.09%

.042l

2.74%

0.79%

<.001l

2.41%

0.68%

<.001l

.53n

.02n

Incident HIVk, n

3

33

 

5

39

 

7

33

 

9

21

   

% positivesi

75.0%

68.8%

.80l

71.4%

81.3%

.54l

63.6%

80.5%

.24l

64.3%

55.3%

.56l

.62n

.22n

% testsf

0.73%

0.52%

.85l

1.02%

0.54%

.11l

0.94%

0.37%

<.001l

0.79%

0.20%

<.001l

.86n

<.001n

% people testedg

1.18%

0.83%

.56l

1.73%

0.88%

.15l

1.76%

0.64%

.011l

1.56%

0.38%

<.001l

.76n

.001n

(95%CI)

(0.38–3.60%)

(0.59–1.17%)

 

(0.72–4.09%)

(0.65–1.21%)

 

(0.84–3.65%)

(0.45–0.90%)

 

(0.81–2.98%)

(0.25–0.58%)

   
  1. a. Born in one of 26 South, East and Southeast Asian countries and year of arrival in Australia 4 years or less than the year of the HIV test
  2. b. Number of individuals who met the criteria at any time during that year
  3. c. Number of individuals did not meet the criteria at any time during the study period
  4. d. HIV tests with a known date of previous negative HIV test only were included
  5. e. Age on the day of the first HIV test during the year
  6. f. Patients were ask if they were taking PrEP from March 2016
  7. g. Number and proportion of tests or testing episodes meeting criteria at the time of the test during the study year
  8. h. Number and proportion of individuals tested meeting criteria at any time during the study year
  9. i. Sexual behaviour as reported in the three months prior to testing
  10. j. Confirmed HIV infection in an individual with no prior known positive HIV test
  11. k. Diagnosis with a negative test in the past 365 days or diagnosis with negative or indeterminate Western blot
  12. l. chi squared
  13. m. Wilcoxon rank-sum (Mann-Whitney) test
  14. n. P trend